General Information of DME (ID: DME1048)
DME Name Oxygen-insensitive NADPH nitroreductase B (nfsB), Escherichia coli
Synonyms Oxygen-insensitive NAD(P)H nitroreductase B; Dihydropteridine reductase; FMN-dependent nitroreductase; JW0567; b0578; ntr; pnrB
Gene Name nfsB
UniProt ID
NFSB_ECOLI
Gene ID
945778
EC Number    EC: 1.5.1.34     (Click to Show/Hide the Complete EC Tree)
Oxidoreductase
CH-NH donor oxidoreductase
NAD/NADP acceptor oxidoreductase
EC: 1.5.1.34
Lineage    Species: Escherichia coli     (Click to Show/Hide the Complete Species Lineage)
Kingdom: Bacteria
Phylum: Proteobacteria
Class: Gammaproteobacteria
Order: Enterobacterales
Family: Enterobacteriaceae
Genus: Escherichia
Species: Escherichia coli
Interactome
(loading-time for this interactome depdends on the speed of web connection)
       Interactions between Xenobiotics and DME (XEOTIC)                      
Jump to Detailed Interactome Data                      
       Interactions between Host Protein and DME (HOSPPI)                     
Jump to Detailed Interactome Data                      
      Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Pathway/Function) of This DME
Tissue Distribution Primarily distributed in human gut.
Sequence
MDIISVALKRHSTKAFDASKKLTPEQAEQIKTLLQYSPSSTNSQPWHFIVASTEEGKARV
AKSAAGNYVFNERKMLDASHVVVFCAKTAMDDVWLKLVVDQEDADGRFATPEAKAANDKG
RKFFADMHRKDLHDDAEWMAKQVYLNVGNFLLGVAALGLDAVPIEGFDAAILDAEFGLKE
KGYTSLVVVPVGHHSVEDFNATLPKSRLPQNITLTEV
Structure
1DS7 ; 1ICR ; 1ICU ; 1ICV ; 1IDT ; 1OO5 ; 1OO6 ; 1OON ; 1OOQ ; 1YKI ; 1YLR ; 1YLU ; 3X21 ; 3X22
Pathway Microbial metabolism in diverse environments (ecj01120 )
Nitrotoluene degradation (ecj00633 )
Function This enzyme can reduce a variety of nitroaromatic compounds using NADH (and to lesser extent NADPH) as source of reducing equivalents; two electrons are transferred. And it can reduce nitrofurazone, quinones and the anti-tumor agent CB1954 (5-(aziridin-1-yl)-2,4-dinitrobenzamide).
Full List of Drug(s) Metabolized by This DME
      Drugs Approved by FDA Click to Show/Hide the Full List of Drugs:          2 Drugs
Nifurtimox
Drug Info Approved Chagas disease ICD11: 1F53 [1]
Clonazepam
Drug Info Approved Epilepsy ICD11: 8A60 [2]
      Drugs in Phase 4 Clinical Trial Click to Show/Hide the Full List of Drugs:          1 Drugs
Flunitrazepam
Drug Info Phase 4 Insomnia ICD11: 7A00 [3]
      Drugs in Phase 3 Clinical Trial Click to Show/Hide the Full List of Drugs:          2 Drugs
Nitrazepam
Drug Info Phase 3 Insomnia ICD11: 7A00 [4]
Nitrofural
Drug Info Phase 3 Acute tonsillitis ICD11: CA03 [4]
      Discontinued/withdrawn Drugs Click to Show/Hide the Full List of Drugs:          1 Drugs
CBL-954
Drug Info Discontinued Hepatocellular carcinoma ICD11: 2C12 [4], [5]
      Preclinical/investigative Agents Click to Show/Hide the Full List of Drugs:          3 Drugs
Misonidazole
Drug Info Investigative Discovery agent ICD: N.A. [6]
Nitrobenzodiazepine
Drug Info Investigative Discovery agent ICD: N.A. [3]
Nitrobenzodiazepine
Drug Info Investigative Discovery agent ICD: N.A. [2], [3]
Full List of Metabolic Reactions (MR) Catalyzed by This DME
MR ID Reactant Product MR Type Source Drug REF
MR005923 CBL-954 The hydroxylamine metabolite Unclear - Unclear CBL-954 [7]
MR005296 CL-205086 Unclear Reduction - Reduction CL-205086 [8]
MR007195 Flunitrazepam 7-amino-unitrazepam Reduction - Reduction Flunitrazepam [3], [9], [10]
MR005550 Nifurtimox Nifurtimox M2 Reduction - Reduction Nifurtimox [1]
MR005551 Nifurtimox Nifurtimox M1 Reduction - Reduction Nifurtimox [1]
MR005552 Nifurtimox Nifurtimox M17 Reduction - Reduction Nifurtimox [1], [11]
MR004374 Nitrobenzodiazepine 7-Amino-benzodiazepine Reduction - Reduction Nitrobenzodiazepine [2], [3]
⏷ Show the Full List of 7 MR(s)
References
1 Structural and Mechanistic Investigation of the Unusual Metabolism of Nifurtimox
2 Characterization of Escherichia coli nitroreductase NfsB in the metabolism of nitrobenzodiazepines. Biochem Pharmacol. 2009 Jul 1;78(1):96-103.
3 Structure-based development of bacterial nitroreductase against nitrobenzodiazepine-induced hypnosis. Biochem Pharmacol. 2012 Jun 15;83(12):1690-9.
4 Conversion of NfsB, a minor Escherichia coli nitroreductase, to a flavin reductase similar in biochemical properties to FRase I, the major flavin reductase in Vibrio fischeri, by a single amino acid substitution. J Bacteriol. 1996 Aug;178(15):4731-3.
5 Discovery and evaluation of Escherichia coli nitroreductases that activate the anti-cancer prodrug CB1954. Biochem Pharmacol. 2010 Mar 1;79(5):678-87.
6 Metronidazole (flagyl) and misonidazole (Ro-07-0582): reduction by facultative anaerobes and cytotoxic action on hypoxic bacteria and mammalian cells in vivo. Br J Cancer Suppl. 1978 Jun;3:132-5.
7 Bystander or no bystander for gene directed enzyme prodrug therapy
8 Delamanid is not metabolized by Salmonella or human nitroreductases: a possible mechanism for the lack of mutagenicity. Regul Toxicol Pharmacol. 2017 Mar;84:1-8.
9 NADPH-cytochrome P-450 reductase is involved in flunitrazepam reductive metabolism in Hep G2 and Hep 3B cells
10 Flunitrazepam oxidative metabolism in human liver microsomes: involvement of CYP2C19 and CYP3A4. Xenobiotica. 1999 Oct;29(10):973-86.
11 Nifurtimox activation by trypanosomal type I nitroreductases generates cytotoxic nitrile metabolites

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.